MedTrace Logo

Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening

NCT05989464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2023-08-25

No results posted yet for this study

Summary

In this study, the investigators will assess whether implementing a self-swab protocol for primary Human Papilloma Virus (HPV) testing is an effective method to increase cervical cancer screening in a sample of unscreened women in Hawaii. The findings of this study may support adoption of HPV self swab protocols both at Kalihi Palama Health Center (KPHC) and other Federally Qualified Health Centers (FQHC) in Hawaii.

Conditions

Interventions

DIAGNOSTIC_TEST

Self-swab for genital HPV

Participants will insert a swab in the vagina to collect a sample for HPV testing.

Sponsors & Collaborators

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Ann Chang, MD · University of Hawaii

Eligibility

Min Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-08
Primary Completion
2024-12-01
Completion
2025-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05989464 on ClinicalTrials.gov